Key Details
Price
$1.22Annual Revenue
$0.00Annual ROE
-33.91%Beta
2.22Events Calendar
Next earnings date:
Apr 30, 2025Recent quarterly earnings:
Feb 27, 2025Recent annual earnings:
Feb 27, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Dec 5, 24 Goldman Sachs
SellJun 27, 24 Guggenheim
BuyAug 3, 23 Morgan Stanley
Equal-WeightAug 3, 22 Morgan Stanley
Equal-WeightAug 3, 22 Goldman Sachs
NeutralJul 14, 22 Goldman Sachs
NeutralApr 13, 22 Goldman Sachs
NeutralJan 6, 22 Morgan Stanley
Equal-WeightNov 2, 21 Cowen & Co.
OutperformAug 4, 21 Goldman Sachs
NeutralMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Nautilus Biotechnology doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Nautilus Biotechnology?
- Does Nautilus Biotechnology pay dividends?
- What sector is Nautilus Biotechnology in?
- What industry is Nautilus Biotechnology in?
- What country is Nautilus Biotechnology based in?
- When did Nautilus Biotechnology go public?
- Is Nautilus Biotechnology in the S&P 500?
- Is Nautilus Biotechnology in the NASDAQ 100?
- Is Nautilus Biotechnology in the Dow Jones?
- When was Nautilus Biotechnology's last earnings report?
- When does Nautilus Biotechnology report earnings?
- Should I buy Nautilus Biotechnology stock now?
What is the ticker symbol for Nautilus Biotechnology?
The ticker symbol for Nautilus Biotechnology is NASDAQ:NAUT
Does Nautilus Biotechnology pay dividends?
No, Nautilus Biotechnology does not pay dividends
What sector is Nautilus Biotechnology in?
Nautilus Biotechnology is in the Healthcare sector
What industry is Nautilus Biotechnology in?
Nautilus Biotechnology is in the Biotechnology industry
What country is Nautilus Biotechnology based in?
Nautilus Biotechnology is headquartered in United States
When did Nautilus Biotechnology go public?
Nautilus Biotechnology's initial public offering (IPO) was on August 7, 2020
Is Nautilus Biotechnology in the S&P 500?
No, Nautilus Biotechnology is not included in the S&P 500 index
Is Nautilus Biotechnology in the NASDAQ 100?
No, Nautilus Biotechnology is not included in the NASDAQ 100 index
Is Nautilus Biotechnology in the Dow Jones?
No, Nautilus Biotechnology is not included in the Dow Jones index
When was Nautilus Biotechnology's last earnings report?
Nautilus Biotechnology's most recent earnings report was on Feb 27, 2025
When does Nautilus Biotechnology report earnings?
The next expected earnings date for Nautilus Biotechnology is Apr 30, 2025
Should I buy Nautilus Biotechnology stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions